[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Bauersachs et al., 2024 - Google Patents

Novel human neurodevelopmental and neurodegenerative disease associated with IRF2BPL gene variants—mechanisms and therapeutic avenues

Bauersachs et al., 2024

View PDF
Document ID
7213705151514945967
Author
Bauersachs D
Bomholtz L
del Rey Mateos S
Kühn R
Lisowski P
Publication year
Publication venue
Frontiers in Neuroscience

External Links

Snippet

Recently a broad range of phenotypic abnormalities related to the neurodevelopmental and neurodegenerative disorder NEDAMSS (Neurodevelopmental Disorder with Regression, Abnormal Movements, Loss of Speech, and Seizures) have been associated with rare single …
Continue reading at www.frontiersin.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Prasuhn et al. Targeting mitochondrial impairment in Parkinson's disease: challenges and opportunities
Stoddard-Bennett et al. Treatment of Parkinson’s disease through personalized medicine and induced pluripotent stem cells
Taroni et al. Pathways to motor incoordination: the inherited ataxias
Slaugenhaupt et al. Rescue of a human mRNA splicing defect by the plant cytokinin kinetin
Abramov et al. Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations
Savaskan et al. Molecular biology of glutathione peroxidase 4: from genomic structure to developmental expression and neural function
Takeuchi et al. Roles of jumonji and jumonji family genes in chromatin regulation and development
Alisch et al. Differentially methylated plasticity genes in the amygdala of young primates are linked to anxious temperament, an at risk phenotype for anxiety and depressive disorders
Waseem Bihaqi et al. Do epigenetic pathways initiate late onset Alzheimer disease (LOAD): towards a new paradigm
Alkanli et al. CRISPR/Cas9 mediated therapeutic approach in Huntington’s disease
Osete et al. Lithium increases mitochondrial respiration in iPSC-derived neural precursor cells from lithium responders
Osorio et al. Concise review: stem cell-based treatment of Pelizaeus-Merzbacher disease
Merelo et al. Associating schizophrenia, long non-coding RNAs and neurostructural dynamics
Harris et al. Ethical and regulatory issues of stem cell-derived 3-dimensional organoid and tissue therapy for personalised regenerative medicine
Livesey Human stem cell models of dementia
Shen et al. miR‐181d‐5p promotes neurite outgrowth in PC12 Cells via PI3K/Akt pathway
López-Márquez et al. CRISPR/Cas9-mediated allele-specific disruption of a dominant COL6A1 pathogenic variant improves collagen VI network in patient fibroblasts
Baltanás et al. The childhood-onset neurodegeneration with cerebellar atrophy (Condca) disease caused by agtpbp1 gene mutations: The purkinje cell degeneration mouse as an animal model for the study of this human disease
Giorda et al. Selective disruption of muscle and brain-specific BPAG1 isoforms in a girl with a 6; 15 translocation, cognitive and motor delay, and tracheo-oesophageal atresia
Mirzaei et al. Bioinformatics analysis of microtubule-associated protein-1 light chain 3 (MAP1LC3A) and (BECN1) genes in autophagy
Higo et al. Increased expression of the growth‐associated protein 43 gene in the sensorimotor cortex of the macaque monkey after lesioning the lateral corticospinal tract
Mao et al. Identification and Functional Analysis of a SLC 33 A 1: c. 339 T> G (p. S er113 A rg) Variant in the Original SPG 42 Family
Fan et al. AS3MT polymorphism: a risk factor for epilepsy susceptibility and adverse drug reactions to valproic acid and oxcarbazepine treatment in children from South China
She et al. Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins
Slone et al. The current landscape for the treatment of mitochondrial disorders